Skip to main content

Option Care Health, Inc. (OPCH) Stock Analysis

Oversold Bounce setup

Buy WaitVALUE-TRAP 1/5Moderate Confidence

Healthcare · Medical Care Facilities

Earnings in 0 days (2026-04-30). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Wait — supporting gate not met yet. Price is at or below entry $27.61 but weak momentum; below 200-day MA (death cross) still blocks BUY_NOW. Key risks: Concentration risk — Supplier: top-4 pharmaceutical vendors (68.0%); Concentration risk — Customer: MCOs and non-governmental payers (88.0%).

Option Care Health is the largest independent provider of home and alternate site infusion services, operating through 196 locations in 43 states across the U.S. It earns revenue by dispensing pharmaceuticals and managing infusion therapy for patients with complex chronic... Read more

$18.94+86.6% A.UpsideScore 4.8/10#23 of 27 Medical Care Facilities
Entry $27.61(Support Atr Sticky)Stop $24.90Target $34.88(analyst − 13%)A.R:R 5.9:1
Analyst target$40.09+111.7%11 analysts
$34.88our TP
$18.94price
$40.09mean
$45

Wait — supporting gate not met yet. Price is at or below entry $27.61 but weak momentum; below 200-day MA (death cross) still blocks BUY_NOW. Key risks: Concentration risk — Supplier: top-4 pharmaceutical vendors (68.0%); Concentration risk — Customer: MCOs and non-governmental payers (88.0%). Chart setup: Oversold RSI 11, near Bollinger lower, volume surge. Earnings in 0 days. Wait until post-earnings. Score 4.8/10, moderate confidence.

Passes 4/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA) and earnings proximity 0d<=7d. Suitability: aggressive.

Thesis

Rewards
No bull case signals
Risks
Concentration risk — Supplier: top-4 pharmaceutical vendors (68.0%)
Concentration risk — Customer: MCOs and non-governmental payers (88.0%)

Key Metrics

P/E (TTM)21.2
P/E (Fwd)12.6
Mkt Cap$4.2B
EV/EBITDA12.8
Profit Mgn3.7%
ROE15.2%
Rev Growth8.8%
Beta0.95
DividendNone
Rating analysts18

Quality Signals

Piotroski F7/9

Options Flow

P/C1.77bearish
IV62%elevated
Max Pain$20+5.6% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHSuppliertop-4 pharmaceutical vendors68%
    10-K Item 1A: 'approximately 68% of our pharmaceutical and medical supply purchases were from four vendors'
  • HIGHCustomerMCOs and non-governmental payers88%
    10-K Item 1A: '88% of our revenue came from MCOs and other non-governmental payers, including Medicare Advantage plans, Managed Medicaid plans'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

3 floor-breakers

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Obv
1.0
Ma Position
1.0
Vol Acceleration
1.5
Rsi
3.0
Volume
10.0
Capitulation risk (RSI 11, below 200MA)Volume distribution (falling OBV)Below 200-MA, MA slope -1.8%/30d — confirmed downtrendVolume surge (3.5x avg) on selloff

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
2.3
Revenue Growth
4.7

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
3.8
Quality Rank
4.9
Value Rank
5.4
GatesMomentum 2.8<4.5Death cross (50MA < 200MA)EARNINGS PROXIMITY 0d<=7dA.R:R 5.9 ≥ 1.5Insider activity: OKNo SEC red flagsSEMI CYCLE PEAK CLEAROversold BounceSuitability: Aggressive
RSI
11 · Oversold
20D MA 50D MA 200D MADEATH CROSSSupport $18.01Resistance $29.80

Price Targets

$25
$28
$35
A.Upside+84.2%
A.R:R5.9:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Earnings in 0 days - binary event risk
! Momentum score 2.8/10 — below 4.5 minimum
! Death cross — 50-day MA below 200-day MA

Earnings

B
M
M
M
1/4 beats
Next Earnings2026-04-30 (0d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is OPCH stock a buy right now?

Wait — supporting gate not met yet. Price is at or below entry $27.61 but weak momentum; below 200-day MA (death cross) still blocks BUY_NOW. Key risks: Concentration risk — Supplier: top-4 pharmaceutical vendors (68.0%); Concentration risk — Customer: MCOs and non-governmental payers (88.0%). Chart setup: Oversold RSI 11, near Bollinger lower, volume surge. Earnings in 0 days. Wait until post-earnings. Target $34.88 (+84.2%), stop $24.90 (−-23.9%), Setup A.R:R 13.3:1. Score 4.8/10, moderate confidence.

What is the OPCH stock price target?

Take-profit target: $34.88 (+86.6% upside). Target $34.88 (+84.2%), stop $24.90 (−-23.9%), Setup A.R:R 13.3:1. Stop-loss: $24.90.

What are the risks of investing in OPCH?

Concentration risk — Supplier: top-4 pharmaceutical vendors (68.0%); Concentration risk — Customer: MCOs and non-governmental payers (88.0%).

Is OPCH overvalued or undervalued?

Option Care Health, Inc. trades at a P/E of 21.2 (forward 12.6). TrendMatrix value score: 7.3/10. Verdict: Buy (Wait for Entry).

What do analysts say about OPCH?

18 analysts cover OPCH with a consensus score of 4.3/5. Average price target: $40.

What does Option Care Health, Inc. do?Option Care Health is the largest independent provider of home and alternate site infusion services, operating through...

Option Care Health is the largest independent provider of home and alternate site infusion services, operating through 196 locations in 43 states across the U.S. It earns revenue by dispensing pharmaceuticals and managing infusion therapy for patients with complex chronic conditions, billing primarily to MCOs, Medicare Advantage, and managed Medicaid plans.

Related stocks: AVAH (Aveanna Healthcare Holdings Inc) · ADUS (Addus HomeCare Corporation) · CON (Concentra Group Holdings Parent) · UHS (Universal Health Services, Inc.) · ASTH (Astrana Health Inc.)